News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncClub: Join the Chat on Trending Trials in Cancer
| In-person and virtual events just for HCPs

Management of Beta-Thalassemia

home / peer-exchange / managementofbetathal
Overview of Beta Thalassemia

EP. 1: Overview of Beta Thalassemia

January 31st 2020
Prevalence and Clinical Presentation of B-Thalassemia

EP. 2: Prevalence and Clinical Presentation of B-Thalassemia

January 31st 2020
β-Thalassemia Severity and Impact on Patients

EP. 3: β-Thalassemia Severity and Impact on Patients

January 31st 2020
Impact of β-Thalassemia on the Providers

EP. 4: Impact of β-Thalassemia on the Providers

January 31st 2020
Current Approaches for Beta-Thalassemia

EP. 5: Current Approaches for Beta-Thalassemia

January 31st 2020
The Role of Transfusion for Beta-Thalassemia

EP. 6: The Role of Transfusion for Beta-Thalassemia

January 31st 2020
Understanding Transfusion for Beta-Thalassemia

EP. 7: Understanding Transfusion for Beta-Thalassemia

January 31st 2020
Iron Dysregulation & Allogeneic Stem Cell Transplantation

EP. 8: Iron Dysregulation & Allogeneic Stem Cell Transplantation

January 31st 2020
Approval of Novel Therapy for Beta-Thalassemia

EP. 9: Approval of Novel Therapy for Beta-Thalassemia

January 31st 2020
End Points of Phase III Study for Beta-Thalassemia

EP. 10: End Points of Phase III Study for Beta-Thalassemia

January 31st 2020
Future Impact of the Novel Therapy for Beta-Thalassemia

EP. 11: Future Impact of the Novel Therapy for Beta-Thalassemia

January 31st 2020
The Potential for Gene Therapy in Beta-Thalassemia

EP. 12: The Potential for Gene Therapy in Beta-Thalassemia

January 31st 2020
The Process for Gene Therapy in Beta-Thalassemia

EP. 13: The Process for Gene Therapy in Beta-Thalassemia

January 31st 2020
The Cost and Safety of Gene Therapy in Beta-Thalassemia

EP. 14: The Cost and Safety of Gene Therapy in Beta-Thalassemia

January 31st 2020
Pipeline Agents for the Treatment of Beta-Thalassemia

EP. 15: Pipeline Agents for the Treatment of Beta-Thalassemia

January 31st 2020
Final Thoughts on the Treatment of Beta-Thalassemia

EP. 16: Final Thoughts on the Treatment of Beta-Thalassemia

January 31st 2020

Latest Conference Coverage

Tusamitamab Ravtansine Plus Pembrolizumab With or Without Chemo Elicits Responses in CEACAM5+ NSCLC

Cemiplimab Monotherapy Induces Durable OS, PFS Benefits in PD-L1+ NSCLC With Brain Metastases

Four Cycles of Chemotherapy Plus Tremelimumab and Durvalumab Demonstrate Optimized Outcomes in Metastatic NSCLC

Taletrectinib Elicits Durable Responses in TKI-Naïve and Crizotinib-Pretreated ROS1+ NSCLC

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact